Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
One thing I noticed from today's PR. Waggs says "we have meetings scheduled with potential strategic partners, biotech companies that have expressed an interest in PharmaCyte and numerous other industry thought leaders who have reached out to us to learn more about PharmaCyte."
Normally he says they have companies interested in working with PMCB on their upcoming trial in LAPC. In this case he states that they'll be meeting with other biotech companies that have expressed an interest in PharmaCyte.
Reading into this, looks like BIO could easily lead to a partnership, if the right offer comes along.
With the progress we've made to advance to (and thru) a pivotal clinical trail, I'd say the offers are getting better all the time.
God Bless
Keep in mind that TD2 and Imaging Endpoints are the best of the best.
These organizations are carefully where they invest their time and energy.
Dr. Korn is founder and CMO of Imaging Endpoints.
Susan Tessmann is Director of Clinical Operations for TD2.
These two, along with Dr. Lohr, presented in our behalf.
Although the details were not provided (which angers me as well) I'm sure the updates were positive.
Keep focused on the finish line and not on distractions!
God Bless.
Brian is connecting the dots (for us).
Deep 6 AI has solidified a partnership with TD2 who is CRO for our upcoming trial.
If you connect the dots, you can derive the fact that PMCB's upcoming clinical trial (and future trials) will benefit from Deep 6's technology.
If you ask me, the combination of Deep 6's AI along with PMCB's CIAB could drastically shorten the timeline of improving patient's lives.
The feeling deep down in my gut is telling me to buy as much PMCB as I can at these levels.
A year from now it will be us looking back laughing and patting ourselves on the back.
God Bless!
I agree, great info!
Personally, I think this is part of the reason we haven't heard from Gately or TD2 yet.
Anyone else think the stars are finally aligned?
Manufacturing is covered and owned/operated by PMCB partners Austrianova. They've made major strides in terms of the manufacturing/cell banking/cGMP side. They're on the fore-front of cell encapsulation from a technology standpoint.
PMCB Pivotal clinical trial is in the perfect hands (TD2, Facet, Hidalgo, Lohr, etc.) with the perfect complimentary parts, which now includes Deep 6 AI to identify patient targets within minutes.
We've added a few big dogs on the business side. Yuen and Makowka know why they joined PMCB and it's because they know that if handled correctly, this pivotal trial could lead to a REVOLUTION in medicine. With that comes the return for us longs both financially and spiritually knowing we've weathered the storm and also patients lives will improve.
The technology speaks for itself and this pivotal trial will prove how versatile it really is.
God Bless.
Hit em straight partner!
Brian-
This is epic! This really puts a damper on the whole "Pump N Dump" "Waggs is evil" movement.
It won't be long until PMCB is in the portfolio of every institutional investment firm in the world. At that time it will be dollars.
GO PMCB!
God Bless
PMCB man you guys are teaching me patience lol.
AST Research Inc. Founded by Thomas Yuen.
Address:
16215 Alton Parkway
P.O. Box 19658
Irvine, California 92713-9658
U.S.A.
Telephone: (714) 727-4141
Fax: (714) 727-9355
Public Company
Incorporated: 1980
Employees: 4,000
Sales: $944.10 million
Stock Exchanges: New York
SICs: 3571 Electronic Computers
Company History:
AST Research Inc., is the third-largest American manufacturer of personal computers based on the industry standard microprocessing chip. In its short history, the company has grown dramatically from a small endeavor started by three friends, to a major power in the computer business, with markets throughout the world.
The story of AST's genesis is a classic tale of a California computer company that was started on a shoe-string and rocketed to wealth and prominence on the strength of technological innovation. The company was founded by Thomas C. K. Yuen, who talked two friends into taking on extra jobs as computer consultants in 1979. The three pooled their spare cash--a total of $2,000--and started the company they named with the initials of the their first names. Albert C. Wong, Yuen's old roommate from Orange Coast College, contributed the "A"; Safi U. Qureshey, who had met Yuen while working at minicomputer maker Computer Automation, Inc., contributed the "S"; and Thomas Yuen, the son of a Hong Kong textile company limousine driver, contributed the "T."
In the spirit of equality, the three friends, all immigrants who had been trained as engineers, drew straws to determine who would take what office in the new company. Qureshey, originally from Pakistan, became president; Wong, from Hong Kong, became secretary; and Yuen took over the post of treasurer. The company was incorporated in 1980, but it was not until 1981 that the three principals of AST had an idea for their first product.
Good point Mens Et. I forgot all about this guy Sandja.
Really stinks being here in the dark but any moment we could hear news on partnership, funding, IND submission, etc.
Now is not the time to give up. We as shareholders need to continue to talk about what's important and that's getting CIAB to trial for PC.
How can you say it hasn't attracted the attention of oncologists when Dr Von Hoff called Crabtree and Waggs?
I re-read today's PR and it sounds to me like the FDA loves CypCaps(TM) and CIAB(TM) technology.
They are basically giving us a piggy back to a successful pivotal trial.
God bless!
Personally it's tough not to be somewhat letdown BUT at the end of the day it all comes down to does CIAB work and can it be developed to become an awesome treatment platform?
I think the answer is yes and (again) personally speaking, I think CIAB will win awards within the next 2-3 years.
We as longs should remain excited and continue to grow exceedingly excited as we got great feedback from the FDA.
More and more people are coming on board and TD2 has been validated numerous times over. THE Q&A with the CEO of TD2 will be cool!
Thank God this technology is back and better then ever!
God bless!
Looking forward to this awesome update! Waggs said before that the team he has aligned here is working to make medical history. They are all here because they know that ultimately Cell-In-A-Box as a therapy platform is brilliant. They've connected the dots as most of us who've been here have long ago.
Whatever Waggs says in 3 hours I believe will pave the way for CIAB to finally get on the big stage and prove itself after a long rollercoaster ride of a past.
Today could potentially rock the foundation!
God Bless!
"Also, I will highlight what we have been working on in the areas of a therapy for malignant ascites, a therapy for Type 1 and insulin-dependent Type 2 diabetes and a therapy for other diseases using cannabinoids rather than traditional chemotherapy agents.""
WOOO HOOOOO!!!!!!!!!!!!!!!!!!!!!
This will be an awesome call! Especially considering the analysts and Big Pharma reps that will be listening in.
I close my eyes and see us as a major player in less then a year.
God Bless!
TBI the person besides Waggs is not Jones it is Mathias Lohr.
It doesn't look like Gately. It actually does look like Steve Case the founder of AOL whose net worth is $1.35 billion.
Can anyone confirm or deny???
I was reading the website for Facet Life Science and it looks like they are experts at dealing with FDA and regulatory process, specifically with orphan drugs (and bio logics their website just so happens to mention). Based on what I saw on website the Orphan Grant applications are due Oct. 14, 2016 and funding for grantees is expected in March 2017..
Did Facet help us get grant money from FDA?? I thoughtink so!,
Sorry on iPad
Maybe they realize the diabetes market will get rocked by CIAB in 2017 and beyond?
PMCB is the only stock in the world that announces (albeit vaguely) a positive interaction with the FDA and proceeds to go down.
Evil knows no bounds I suppose.
Ground control to Major Tom!
We are set for take off.
More importantly, once this technology hits the clinic and is utilized in the body, people stricken with cancerous tumors will finally have hope.
God bless this technology and the team whose spearheading the efforts to bring it to market.
Great article! It's about time long term investors start backing up the trucks to load shares.
Anyone with a bit of foresight can see that Dr. Hidalgo and Dr. Von Hoff are going to utilize CIAB to change the world!
CIAB is the most versatile treatment system around and it's ready to showcase that within the next couple months.
Good luck and God bless!
Only a matter of time now.
Would be silly to not have a long position and ride this out.
Congrats is in order for those of us who have had the foresight to see this all coming together.
We will have out vindication!
I wrote an email to investor relations asking if PMCB has a date set with the FDA.
Per IR "Thank you for your email and interested in Pharmacyte Biotech. Yes, the date for PharmaCyte's pre-IND meeting with the FDA has already been scheduled."
AWESOME!!!!! I wonder if Von Hoff will be there with Waggs and the crew?
Considering the first was last Weds, I thought we might see our 2nd interview in the series of interviews with folks associated with PMCB's upcoming trial.
Oh well.
Maybe the next one will be Von Hoff talking about CIAB's potential and the future he sees for this platform technology.
Brian,
Correct me if I am wrong:
Based on our "at-the-market" funding agreement, they will try as hard as they can now to keep the PPS lower then it would be organically so that it takes more shares to come up with the 6-8 million needed to fund the trials?
My first NVLX buy was March 27, 2013.
boy do I feel good today as it all comes to fruition.
God Bless!
We have to do something about this?
Was there a response from the company?
I think Brian said he would send them an email.
This is ridiculous and obvious manipulation..
God Bless the team at PMCB and Austrianova.
Honestly I think with the news of the 21st Century Cures Act and other considerations, we are in the midst of a spiritual awakening.
Cell-In-A-Box is going to lead the way.
The timing is right and the stars are aligned.
We will be vindicated.
I doubt that Pete has gone anywhere. He is probably on a plane or something.
And for you, if you're just a flipper/charter/etc. why don't you go ahead and move on?
You're so quick to give up on this it proves that you aren't in it for the long haul.
One day this is going to take off and never return to these levels.
Just wait and watch.
God Bless
This is still a discount at these prices.
All signs point to a successful relationship with the FDA.
Will Von Hoff and/or Hidalgo be present at the pre-IND meeting?
This is just getting started.
The best is yet to come!
God Bless CIAB and PMCB.
Count me in Pete!
Shots of Louis XIII
I love the fact that Dr. Von Hoff and Hidalgo are confirmed to be tag-teaming this clinical trial.
Why on earth would these two waste 1 second of their days dabbling with a technology that isn't full of potential?
It's proof that they've vetted CIAB and made an informed decision to invest their time and efforts.
Only great things to come for CIAB and PMCB.
God Bless this company and this technology.
Agreed man 100%.
B*ll*hit
Man I really thought this thing would move upwards today!!!
My confidence has not wavered and I know our faith will be rewarded!
PMCB will have its vindication.
More so then the financial gains and the improved treatment for sick patients, I look forward to the day we can say "told ya so"
Guess it's back to buying!
NEWS OUT!
PRE-IND meeting is requested with the FDA!
Won't be long now!
I have my buy order in for this morning!
I'll be topping off my position and waiting for the ride of a lifetime!
If it stays here for the next couple months maybe I'll add some Christmas shares!
There is no way that CIAB can be suppressed forever.
We will have our vindication!
God Bless and Happy Friday!
I agree. I am waiting for my funds to clear (should be this afternoon) so I can top off my position!
Smart money is buying here. It's 4 cents, no brainer.
I'm not a chartist but a visionary investor. It's clear to see that CIAB has a bright future.
The introduction of Dr. Hidalgo as PI has eliminated a lot of risk involved.
Why would he agree to be PI if he didn't think he could make a huge impact with CIAB?
"This novel technology has exceedingly broad application. I am looking forward to working with other clinical oncologists in the U.S. and in Europe to insure that PharmaCyte's therapy meets the critical unmet medical need the study is designed to address."
Can anyone tell me if it's a good thing when one of the best Dc's in the world goes on record saying this?
Just curious if this is a good thing?
CIAB!!!!!!
Appreciate the respect and I respect you as well!
Trust me I've done as much DD as anyone.
What I am trying to say is, why not inform us of all the meetings and behind the scenes work going on?
It couldn't hurt to release 1 PR every week informing us of operational activities.
Either way I've been buying.
I'm patient but would prefer to not go a month without hearing anything.
LOL!
I'm with you RC. This is getting more and more frustrating.
I'd rather have the inconsequential PR's than silence.
Dear KW, Please let us know you are still alive.
Thank you!
From, a LONG that's been invested for over 4 years.